Book a demo

Chemical intelligence powered by cypris.ai

Dubam

methyl 2-hydroxybenzoate · also: MeSal, Betula, Linsal, Sloans, Analgit, Betulol

FormulaC8H8O3
Mol. weight152.149
PubChem CID4133
InChIKeyOSWPMRLSEDHDFF-UHFFFAOYSA-N
SMILESCOC(=O)C1=CC=CC=C1O
52,477Patents
955Research papers
2,755Patents - last 3 years
49Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Aventis Pharmaceuticals Inc1,258
2Procter and Gamble Co1,233
3Colgate Palmolive Co1,045
4Qualcomm Inc563
5Bayer AG551
6Millennium Pharmaceuticals Inc473
7Intercontinental Great Brands LLC451
8SABIC Global Technologies BV387
9General Electric Co302
10Henkel AG and Co KGaA231

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61KMedicinal preparations22,912
2A61PTherapeutic activity (drug indications)17,163
3A61QCosmetics, personal care8,934
4C07DHeterocyclic compounds6,900
5H04N6,288
6C07KPeptides3,381
7C07CAcyclic and carbocyclic compounds2,868
8G01NInvestigating / analysing materials2,400
9C12NMicroorganisms, enzymes2,244
10A01NPreservation of bodies; biocides; pest repellents1,923

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Most-cited patents

Patents ranked by forward citations reveal the foundational inventions the field continues to build on.

TitleYearAssigneeCited by
BAROSSA WINTERGREEN Betula pendula19910

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Insect-Plant Interactions and Control4
2Endodontics and Root Canal Treatments2
3Poisoning and overdose treatments2
4Advancements in Transdermal Drug Delivery1
5Animal Behavior and Reproduction1
6Botanical Research and Chemistry1
7Drug-Induced Adverse Reactions1
8Insects and Parasite Interactions1
9Nematode management and characterization studies1
10Neurological Disorders and Treatments1

Technology trend analysis

Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.

See Cypris in action

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Daniel F. KlessigCornell University10
2Alexandre LacosteDélégation Provence et Corse3
3Bill S. HanssonMax Planck Institute for Chemical Ecology6
4Anna‐Karin Borg‐KarlsonKTH Royal Institute of Technology5
5Birgit PiechullaUniversity of Rostock5
6A. Corina VlotCornell University4
7C. Frieke KuperPension Fund for Care and Well-Being4
8C. M. WoodcockRothamsted Research4
9Daniel ValeroUniversitat de Miguel Hernández d'Elx4
10Denise M. TiemanUniversity of Florida4

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

TitleYearCited byTopic
Bacterial Volatiles Induce Systemic Resistance in Arabidopsis20041294Plant-Microbe Interactions and Immunity
Abiotic stresses and induced BVOCs20101118Plant and animal studies
Methyl Salicylate Is a Critical Mobile Signal for Plant Systemic Acquired Resistance20071049Plant-Microbe Interactions and Immunity
Comprehensive Maps of Drosophila Higher Olfactory Centers: Spatially Segregated Fruit and Pheromone Representation2007702Neurobiology and Insect Physiology Research
Root and canal morphology of Burmese mandibular molars2001566Dental materials and restorations

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the chemical identity and molecular composition of Dubam?

Dubam is the common name for methyl 2-hydroxybenzoate, a compound with the molecular formula C8H8O3 and a molecular weight of 152.149. Its InChI Key is OSWPMRLSEDHDFF-UHFFFAOYSA-N. The compound is known by multiple trade and product names including MeSal, Betula, Linsal, Sloans, Ben Gay, and Radian-b.

What is the patent landscape for Dubam and related compositions?

The patent coverage for Dubam is substantial, with a total of 52,477 patents identified in the database. In the last three years, 2,826 patents have been filed. The leading patent assignees working with this compound are Aventis Pharmaceuticals Inc (1,258 patents), Procter and Gamble Co (1,233 patents), and Colgate Palmolive Co (1,045 patents).

What scientific research topics are associated with Dubam?

Research on Dubam spans multiple domains. A highly cited paper titled 'Methyl Salicylate Is a Critical Mobile Signal for Plant Systemic Acquired Resistance' (2007, 1,044 citations) demonstrates the compound's role in plant immunity. Other research areas include Insect-Plant Interactions and Control, Advancements in Transdermal Drug Delivery, and Olfactory and Sensory Function Studies. A total of 955 papers are associated with Dubam in the literature.

Which patent classification codes are most relevant to Dubam patents?

The dominant CPC subclasses associated with Dubam patents are A61K (22,911 patents), which covers pharmaceuticals and medicinal preparations, and A61P (17,163 patents), which covers therapeutic applications. Other significant classifications include A61Q (8,934 patents) for cosmetic and personal care uses, C07D (6,900 patents) for heterocyclic compounds, and H04N (6,288 patents) for imaging and transmission technologies.

What is the recent publication and patent filing trend for Dubam research?

Patent filing activity for Dubam has been substantial and relatively consistent, with peaks in 2018 (1,809 patents) and 2022 (1,782 patents). In 2024, 1,475 patents were filed. For academic research, there were 955 papers identified in the database, with 49 published in the last three years. The year 2024 showed 22 papers, indicating ongoing scholarly interest in the compound.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial